Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19
Open Access
- 15 April 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (8), 4067
- https://doi.org/10.3390/ijms22084067
Abstract
The family of coronaviruses (CoVs) uses the autophagy machinery of host cells to promote their growth and replication; thus, this process stands out as a potential target to combat COVID-19. Considering the different roles of autophagy during viral infection, including SARS-CoV-2 infection, in this review, we discuss several clinically used drugs that have effects at different stages of autophagy. Among them, we mention (1) lysosomotropic agents, which can prevent CoVs infection by alkalinizing the acid pH in the endolysosomal system, such as chloroquine and hydroxychloroquine, azithromycin, artemisinins, two-pore channel modulators and imatinib; (2) protease inhibitors that can inhibit the proteolytic cleavage of the spike CoVs protein, which is necessary for viral entry into host cells, such as camostat mesylate, lopinavir, umifenovir and teicoplanin and (3) modulators of PI3K/AKT/mTOR signaling pathways, such as rapamycin, heparin, glucocorticoids, angiotensin-converting enzyme inhibitors (IECAs) and cannabidiol. Thus, this review aims to highlight and discuss autophagy-related drugs for COVID-19, from in vitro to in vivo studies. We identified specific compounds that may modulate autophagy and exhibit antiviral properties. We hope that research initiatives and efforts will identify novel or “off-label” drugs that can be used to effectively treat patients infected with SARS-CoV-2, reducing the risk of mortality.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/10863-7; 2019/14722-4 (GJSP); 2019/02821-8 (SSS).)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (421603/2018-6 (GJSP); PVE 401236/2014-5 (SSS); PVE 401141/2014-4 (CB).)
This publication has 277 references indexed in Scilit:
- Divergent Roles of Autophagy in Virus InfectionCells, 2013
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasisBreast Cancer Research and Treatment, 2010
- The Beclin 1 interactomeCurrent Opinion in Cell Biology, 2010
- Purified TPC Isoforms Form NAADP Receptors with Distinct Roles for Ca2+ Signaling and Endolysosomal TraffickingCurrent Biology, 2010
- Autophagy Protects against Sindbis Virus Infection of the Central Nervous SystemCell Host & Microbe, 2010
- Methods in Mammalian Autophagy ResearchCell, 2010
- Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with LysosomesCell Host & Microbe, 2009
- Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in miceBritish Journal of Pharmacology, 2008
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008
- Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthmaFree Radical Biology & Medicine, 2007